全球智库信息集成服务系统(G2TT): Patient Responses to Incentives in Consumer-directed Health Plans: Evidence from Pharmaceuticals

G2TT

来源类型	Working Paper
规范类型	报告
DOI	10.3386/w20927
来源ID	Working Paper 20927
	Patient Responses to Incentives in Consumer-directed Health Plans: Evidence from Pharmaceuticals
	Peter J. Huckfeldt; Amelia Haviland; Ateev Mehrotra; Zachary Wagner; Neeraj Sood
发表日期	2015-02-09
出版年	2015
语种	英语
摘要	Prior studies suggest that consumer-directed health plans (CDHPs) -characterized by high deductibles and health care accounts- reduce health costs, but there is concern that enrollees indiscriminately reduce use of low-value services (e.g., unnecessary emergency department use) and high-value services (e.g., preventive care). We investigate how CDHP enrollees change use of pharmaceuticals for chronic diseases. We compare two large firms where nearly all employees were switched to CDHPs to firms with conventional health insurance plans. In the first firm’s CDHP, pharmaceuticals were subject to the deductible, while in the second firm pharmaceuticals were exempt. Employees in the first firm shifted the timing of drug purchases to periods with lower cost sharing and were more likely to use lower-cost drugs, but the largest effect of the CDHP was to reduce utilization. Employees in the second firm also reduced utilization, but did not shift the timing or use of low cost drugs.
主题	Health, Education, and Welfare ; Health
URL	https://www.nber.org/papers/w20927
来源智库	National Bureau of Economic Research (United States)
引用统计
资源类型	智库出版物
条目标识符	http://119.78.100.153/handle/2XGU8XDN/578601
推荐引用方式 GB/T 7714	Peter J. Huckfeldt,Amelia Haviland,Ateev Mehrotra,et al. Patient Responses to Incentives in Consumer-directed Health Plans: Evidence from Pharmaceuticals. 2015.